Cover Image
市場調查報告書

美國的心臟缺損封閉設備市場 2016年 (至2022年的預測)

US Market for Heart Defect Closure Devices - 2016 (Forecasted to 2022)

出版商 iData Research Inc. 商品編碼 341887
出版日期 內容資訊 英文 78 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的心臟缺損封閉設備市場 2016年 (至2022年的預測) US Market for Heart Defect Closure Devices - 2016 (Forecasted to 2022)
出版日期: 2015年09月01日 內容資訊: 英文 78 Pages
簡介

美國250萬人以上的男女患心房纖維顫動 (AF) 症。由於許多AF患者由於對抗凝固藥的藥物療法猶豫,美國有許多左心耳 (LAA) 封閉設備的對象患者心內膜LAA封閉設備給予LAA管理微創的選項。

本報告提供美國的心臟缺損封閉設備市場相關調查、各市場區隔趨勢分析、市場規模的實際成果與預測、市場推動成長因素與抑制因素、各市場、市場區隔的詳細競爭分析等相關資料彙整。

目錄

圖表

第1章 摘要整理

第2章 調查手法

  • 調查範圍
  • IDATA的9等級的調查手法

第3章 卵圓孔未閉合 (PFO) 設備市場

  • 簡介
  • 手術數
    • PFO設備的縫合手術
  • 市場分析、預測
    • PFO設備市場
  • 促進要素、抑制因素
  • 競爭分析
    • 主要企業
    • 有潛力的企業

第4章 心房中隔缺損 (ASD) 及心室中隔缺損 (VSD) 設備市場

  • 簡介
  • 手術數
    • 中隔缺損設備手術數:各生物結構
  • 市場概要
  • 市場分析、預測
    • ASD 及 VSD 設備市場整體
    • ASD 設備市場
    • VSD 設備市場
  • 促進要素、抑制因素
  • 競爭分析

第5章 左心耳 (LAA) 封閉設備市場

  • 簡介
  • 手術數
    • LAA封閉手術數:各類型
  • 市場概要
  • 趨勢分析、預測
    • 心外膜設備市場整體
      • 心外膜夾設備市場
      • 心外膜縫合設備市場
  • 促進要素、抑制因素
  • 競爭分析
    • 主要企業
    • 新興企業
    • 有潛力的企業

簡稱

目錄
Product Code: iDATA_USHDC16_RPT

As of August 2015, the FDA had not approved a device for PFO closure. Therefore, device-based patent foramen ovale (PFO) closure procedures are most commonly performed using atrial septal defect (ASD) closure devices being used off-label. Despite the lack of FDA approval, PFO closure remains popular due to the reduced risk of stroke and the reduced frequency of migraines. Over 2.5 million men and women suffer from atrial fibrillation (AF) in the United States. With many AF patients hesitant to take anti-coagulant medication, a huge patient population exists for left atrial appendage (LAA) closure devices in the United States. Endocardial LAA closure devices present a minimally invasive option for LAA management.

As of August 2015, the U.S. market for endocardial LAA closure devices was composed entirely of Boston Scientific's WATCHMAN™ device, which received FDA approval in March 2015. The large AF patient population, reports of negative patient outcomes with other methods of LAA closure and patient preference for minimally invasive treatment techniques will combine to drive unit sales of the endocardial LAA segment to grow at a CAGR in excess of 60% over the forecast period. The rapidly increasing unit sales of the endocardial LAA segment will interact with the high ASP of the WATCHMAN™ to urge massive growth in the value of the total U.S. market for LAA devices.

This Report Includes Segments On:

  • Patent Foramen Ovale Devices
  • Atrial and Ventricular Septal Defect Devices
  • Left Atrial Appendage Closure Device Market

This 78 Page Report Includes:

  • In-depth, Professionally Researched Data That Has Been Formatted and Analyzed to Gain Actionable Insights as Quickly as Possible
  • Executive Summary
  • Trend Analysis by Segment
  • Market Value Forecasts until 2022 and History Back to 2012
  • Market Drivers and Limiters
  • Detailed Competitive Analysis for Each Market and Segment

While PFO closure devices have the largest share of the U.S. market for PFO, ASD & ventricular septal defect (VSD) closure devices, VSD closure devices have the smallest share. Historically, the size of the VSD closure device segment had been limited by the number of patients requiring treatment for VSDs, which has remained much smaller than the number of patients requiring treatment for ASD or PFO. Over 2.5 million men and women suffer from atrial fibrillation (AF) in the United States. With many AF patients hesitant to take anti-coagulant medication, a huge patient population exists for left atrial appendage (LAA) closure devices in the United States.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1 PFO, ASD & VSD DEVICE MARKET
  • 1.2 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET

RESEARCH METHODOLOGY

  • 2.1 RESEARCH SCOPE
  • 2.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

PATENT FORAMEN OVALE DEVICE MARKET

  • 3.1 INTRODUCTION
  • 3.2 PROCEDURE NUMBERS
    • 3.2.1 Patent Foramen Ovale Device Closure Procedures
  • 3.3 MARKET ANALYSIS AND FORECAST
    • 3.3.1 Patent Foramen Ovale Device Market
  • 3.4 DRIVERS AND LIMITERS
    • 3.4.1 Market Drivers
    • 3.4.2 Market Limiters
  • 3.5 COMPETITIVE ANALYSIS
    • 3.5.1 Leading Competitors
    • 3.5.2 Potential Competitors

ATRIAL & VENTRICULAR SEPTAL DEFECT DEVICE MARKET

  • 4.1 INTRODUCTION
  • 4.2 PROCEDURE NUMBERS
    • 4.2.1 Septal Defect Device Procedures by Anatomy
  • 4.3 MARKET OVERVIEW
  • 4.4 MARKET ANALYSIS AND FORECAST
    • 4.4.1 Total Atrial & Ventricular Septal Defect Device Market
    • 4.4.2 Atrial Septal Device Market
    • 4.4.3 Ventricular Septal Device Market
  • 4.5 DRIVERS AND LIMITERS
    • 4.5.1 Market Drivers
    • 4.5.2 Market Limiters
  • 4.6 COMPETITIVE ANALYSIS
    • 4.6.1 Leading Competitors
    • 4.6.2 Potential Competitors

LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET

  • 5.1 INTRODUCTION
  • 5.2 PROCEDURE NUMBERS
    • 5.2.1 LAA Closure Procedures by Type
  • 5.3 MARKET OVERVIEW
  • 5.4 MARKET ANALYSIS AND FORECAST
    • 5.4.1 Total Epicardial Device Market
    • 5.4.1.1 Epicardial Clip Device Market
    • 5.4.1.2 Epicardial Suture Device Market
    • 5.4.2 Endocardial Device Market
  • 5.5 DRIVERS AND LIMITERS
    • 5.5.1 Market Drivers
    • 5.5.2 Market Limiters
  • 5.6 COMPETITIVE ANALYSIS
    • 5.6.1 Leading Competitors
    • 5.6.2 Emerging Competitors
    • 5.6.3 Potential Competitors

ABBREVIATIONS 61

Back to Top